Comprehensive, up-to-date information on HIV/AIDS treatment, prevention, and policy from the University of California San Francisco

CAPS Town Hall: Engaging and Keeping HIV Patients in Care
Katerina A. Christopoulos, Elvin Geng, and Gabriel Chamie presented diverse research on patient engagement and retention in San Francisco General Hospital and Uganda. Each presenter addressed fundamental questions of how to diagnose, engage, and retain patients. Dr. Christopoulos explored ways of defining and measuring linkage and retention, and presented qualitative research on barriers to and facilitators of engagement in care in San Francisco. Dr. Geng discussed the outcomes of the San Francisco "test and treat" policy, tracing drops in viral RNA among this patient population in the last 10 years. Dr. Chamie described the initial pilot of a community engagement study in Uganda, in which members of a Ugandan parish were offered extensive testing, basic preventative care, and linkage to local health services. Presented at the Center for HIV Prevention (CAPS) on April 20, 2012. Note: this educational activity was supported with a gift from Roche Molecular Diagnostics.

The AIDS Epidemic at Year 30: Is There an End in Sight?
Mike McCune, MD, PhD, Professor, Division of Experimental Medicine, University of California San Francisco

Dr. McCune discusses the history of the AIDS epidemic at the University of California San Francisco and San Francisco General Hospital, reviews the interventions that have made an impact on HIV transmission and disease progression, and outlines strategies that could lead to eradication of HIV on a worldwide basis. This talk was presented at San Francisco General Hospital's Grand Rounds on November 29, 2011.

Treatment Guidelines and the Interface with Prevention
Paul A. Volberding, MD, Vice Chair of the Department of Medicine at UCSF, Director of CFAR, and Chief of Medical Services at the San Francisco VA Medical Center

Dr. Volberding discusses the recent shifts in U.S. HIV treatment guidelines, especially regarding early initiation of ART, and reviews data on efficacy of ARVs in preventing sexual transmission of HIV. Presented at the Center for HIV Prevention (CAPS) on June 1, 2011. Note: this educational activity was supported with a gift from Roche Molecular Diagnostics.

Management and Treatment of HCV Infection: Entering a New Era in 2011
Phyllis C. Tien, MD, Associate Professor of Medicine, UCSF; Staff Physician, SFVAMC

In this presentation, Dr. Phyllis Tien reviews recent studies of hepatitis C (HCV) management and treatment. She describes the evolving range of agents available for treatment, including new direct-acting antiviral agents approved by the FDA. She notes contraindications for treatment and reasons for individualized care, concluding with a perspective on future trends in HIV and HCV care. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on May 4, 2011. (1 CME credit)

Conception and Contraception for HIV-Affected Couples
Deborah Cohan, MD, Associate Professor, UCSF; Medical Director, Bay Area Perinatal AIDS Center (BAPAC)

Dr. Cohan presents family planning options and preconception care for couples affected by HIV, focusing on strategies for discordant couples to safely conceive healthy, uninfected infants. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on April 20, 2011. (1 CME credit)

Menopause: Reproductive Aging and HIV
Ruth Greenblatt, MD, Professor of Clinical Medicine and Epidemiology, UCSF

Ruth Greenblatt, MD, examines reproductive changes associated with aging in HIV-infected women. In doing so, she discusses how HIV-infected women experience menopause and how reproductive aging affects HIV, including the difficulty of defining menopause in the context of chronic disease, gendered differences in immune function, and the high prevalence of autoimmune disease among women. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on February 23, 2011. (1 CME credit)

Regimen Simplification
Monica Gandhi, MD, MPH, Associate Professor of Medicine, UCSF

Monica Gandhi, MD, MPH, discusses ARV regimen simplification using a case-based format. She reviews data from simplification studies, considerations for making strategic ART changes, and possible risks and benefits of ART simplification. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on December 10, 2010. (1 CME credit)

Cases from the Clinic 2010
Dan Wlodarczyk, MD, Professor of Medicine, UCSF

Dan Wlodarczyk MD, discusses several difficult cases encountered in the course of clinical practice in the HIV clinic at San Francisco General Hospital, which serves a diverse urban underserved patient population. The cases include breast enlargement in a man, pain management, ARV selection for a patient susceptible to allergies, and several challenging adherence issues. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on November 24, 2010. (1 CME credit)

HIV Prevention in San Francisco: Where Do We Go from Here?
Grant Colfax, MD, Director of HIV Prevention and Research, San Francisco Department of Public Health

Grant Colfax, MD, examines changing strategies for HIV prevention in San Francisco. He gives an overview of the characteristics of the San Francisco Department of Public Health's (SFDPH) HIV Prevention Program and discusses its focus on HIV status awareness, prevention with positives (PWP), primary drivers of HIV (such as substance use), and structural interventions to reduce risk. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on October 27, 2010. (1 CME credit)

Challenging Cases of Immunosuppression and Immune Reconstitution
Mark A. Jacobson, MD, Professor of Medicine, UCSF

Mark A. Jacobson, MD, presents 2 cases that illustrate the challenges of diagnosis and management of severely immunocompromised patients. The cases highlight the dilemma of when to start ART with very ill patients in the setting of an acute opportunistic infection, and they address the difficulties of making a differential diagnosis in patients with multiple overlapping conditions. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on September 8, 2010. (1 CME credit)

HIV Infection and Metabolic Bone Disease
Dolores Shoback, MD, Professor of Medicine, UCSF

Dolores Shoback, MD, explains the implications of low bone mass among HIV-infected patients. After providing a description of osteoporosis, Dr. Shoback describes the epidemiology, risk factors, screening recommendations, treatment considerations, and safety concerns associated with low bone mass in HIV-infected people. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on April 21, 2010. (1 CME credit)

Clinical Management of Kidney Disease in HIV Infection
Andy Choi, MD, MAS, Assistant Professor of Medicine, Division of Nephrology, UCSF

Andy Choi gave this presentation on kidney disease in the HIV-infected patient on May 26, 2010, at the San Francisco General Hospital Grand Rounds. Dr. Choi was recognized as an expert on HIV-related kidney disease before his sudden death on August 14, 2010. (1 CME credit)

Management of HCV Infection in the HIV-Infected Patient: Where Are We in 2010?
Phyllis C. Tien, MD, Associate Professor of Medicine, UCSF; Staff Physician, SFVAMC

Phyllis C. Tien, MD, examines strategies for managing HCV in patients with HIV coinfection. She also addresses the epidemiology of HCV, diagnosis and monitoring, and future directions in HCV treatment. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on May 12, 2010. (1 CME credit)

Vaccinations for Adults and Adolescents: Focus on HIV
Lisa Winston, MD, Associate Clinical Professor, UCSF, San Francisco General Hospital

In this presentation Lisa Winston, MD, highlights immunizations that are recommended or contraindicated for HIV-infected adults and adolescents. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on March 31, 2010. (1 CME credit)

HIV and Aging: Paradigm Shift in the Management of HIV Disease
Peter Hunt, MD, Assistant Professor of Medicine, HIV Division, San Francisco General Hospital

Peter Hunt, MD, reviews the available data that suggest accelerated aging processes in HIV-infected persons. He focuses on the causes and impacts of chronic immune activation even in persons on effective antiretroviral therapy. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on February 3, 2010. (1 CME credit)

Cases in HIV Drug Resistance
Harry Lampiris, MD, Professor of Clinical Medicine, UCSF

Harry Lampiris, MD, uses a case-based approach to discuss current issues in the management of virologic failure. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on January 20, 2010. (1 CME credit)

Update on Early and Acute HIV Infection
Frederick Hecht, MD, Professor of Medicine, UCSF

Frederick Hecht, MD, describes clinical, immunologic, and virologic aspects of primary (initial) HIV infection, including transmission of resistant virus and superinfection. His presentation is based upon current research on the biology of HIV transmission and immunopathogenesis of HIV. Presented at SFGH's HIV/AIDS Grand Rounds on December 9, 2009. (1 CME credit)

HIV Psychiatry Update
Robert Daroff, Jr., MD, Director, HIV Psychiatry Program, San Francisco VA Medical Center

Robert Daroff, MD, discusses depression, bipolar depression, and anxiety disorders in the context of HIV infection. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on October 28, 2009. (1 CME credit)

Healthcare of the HIV Positive Transgender Person
Barry Zevin, MD, Assistant Clinical Professor of Medicine, UCSF School of Medicine

This presentation uses 3 cases to discuss HIV prevention, epidemiology, prevalence, and medical management among transgender people. Presented at San Francisco General Hospital's HIV/AIDS Grand Rounds on September 9, 2009. (1 CME credit)

Archives: HIV Grand Rounds at San Francisco General Hospital

Listen to and watch past presentation in the HIV InSite / PHP Grand Rounds archives.

For more information about the Grand Rounds program, see the PHP website.